tropicalgirl
New member
Bad news... Does anyone knows why this delay? Why the gov is buying it from other producers if they can produce it in here? What's going on? Does anyone has more information about this?
****************WARNING AUTOMATIC TRANSLATION**************
17/07/2009 - 17h09
WHO delays and Brazil should not swine flu vaccine this year
In Sao Paulo
The Butantan Institute, São Paulo, has not received the World Health Organization (WHO) formula of swine flu vaccine, expected to be sent at the beginning of the month, making it impossible to production in the country of immunizing against the virus of influenza A (H1N1) this year, according to the advice of the institution. The reason for the delay was not clear and Butantan advised not to act on the matter for now. Unable to start the production in time by the end of this year Brazil will have to fight disease with vaccines imported.
The Butantan is the only laboratory in Latin America where they are manufactured vaccines against common flu and is also the place where the will against influenza A. It is the WHO determines which varieties of flu vaccines are produced worldwide every year. In the case of influenza A, then to monitor the subtypes of the virus circulating in the world, the organization sends a kind of "recipe" of the vaccine for each country. In Brazil's case, this formula should have already arrived.
Information Office of the WHO and they are required to account for at least six months for the vaccine is released to the public, after the receipt of revenue. Before it is necessary to establish whether the vaccine confers immunity and if there is no toxic effect of components. Then the product is tested in animals as mice, only then to be initiated clinical testing in humans.
In an interview granted to the state agency at the end of June, the president of the Butantan Foundation, Isaías Raw, said that the fact of the Institute Adolfo Lutz succeeded in isolating the virus H1N1 should expedite testing with the disease. Raw reminded that the Butantan has the advantages of having the only factory of vaccines in Latin America, the media culture in fertilized eggs and called adjuvant, a product that allows quadruple dose of the substance. He also pointed out to be unnecessary the production of vaccines for the entire population. The Butantan in November to inaugurate a factory with capacity to produce 1 million doses of vaccine.
The Secretary of Science, Technology and Strategic Inputs of the Ministry of Health, Reinaldo Guimarães, said yesterday that the federal government negotiated the purchase of vaccine against the disease, but did not specify how many doses should be acquired. According to information on the Web site folder, not missing drugs to combat disease. "The Ministry of Health has sufficient stock of medicine for treatment of cases indicated. In addition to tablets for immediate use, we have material to produce 9 million more treatments," says the report of the Ministry. The federal government recently bought a batch of 800 thousand doses, of which 50 thousand to reach the country next week and the remainder in September.
Care
Despite the increased number of deaths (11 in the balance of yesterday) and cases of contamination, the recommendations of the Ministry of Health have not changed. Anyone who has symptoms such as sudden fever, cough, headache, joint and muscle pain and rhinorrhea, should seek a doctor or health service, as is common with influenza.
The primary care are: wash hands thoroughly and often with soap and water, avoid touching eyes, mouth and nose after contact with surfaces, do not share personal effects and cover the mouth and nose with disposable tissue when coughing or sneezing.
Source: http://noticias.uol.com.br/ultnot/agencia/2009/07/17/ult4469u43817.jhtm
****************WARNING AUTOMATIC TRANSLATION**************
17/07/2009 - 17h09
WHO delays and Brazil should not swine flu vaccine this year
In Sao Paulo
The Butantan Institute, São Paulo, has not received the World Health Organization (WHO) formula of swine flu vaccine, expected to be sent at the beginning of the month, making it impossible to production in the country of immunizing against the virus of influenza A (H1N1) this year, according to the advice of the institution. The reason for the delay was not clear and Butantan advised not to act on the matter for now. Unable to start the production in time by the end of this year Brazil will have to fight disease with vaccines imported.
The Butantan is the only laboratory in Latin America where they are manufactured vaccines against common flu and is also the place where the will against influenza A. It is the WHO determines which varieties of flu vaccines are produced worldwide every year. In the case of influenza A, then to monitor the subtypes of the virus circulating in the world, the organization sends a kind of "recipe" of the vaccine for each country. In Brazil's case, this formula should have already arrived.
Information Office of the WHO and they are required to account for at least six months for the vaccine is released to the public, after the receipt of revenue. Before it is necessary to establish whether the vaccine confers immunity and if there is no toxic effect of components. Then the product is tested in animals as mice, only then to be initiated clinical testing in humans.
In an interview granted to the state agency at the end of June, the president of the Butantan Foundation, Isaías Raw, said that the fact of the Institute Adolfo Lutz succeeded in isolating the virus H1N1 should expedite testing with the disease. Raw reminded that the Butantan has the advantages of having the only factory of vaccines in Latin America, the media culture in fertilized eggs and called adjuvant, a product that allows quadruple dose of the substance. He also pointed out to be unnecessary the production of vaccines for the entire population. The Butantan in November to inaugurate a factory with capacity to produce 1 million doses of vaccine.
The Secretary of Science, Technology and Strategic Inputs of the Ministry of Health, Reinaldo Guimarães, said yesterday that the federal government negotiated the purchase of vaccine against the disease, but did not specify how many doses should be acquired. According to information on the Web site folder, not missing drugs to combat disease. "The Ministry of Health has sufficient stock of medicine for treatment of cases indicated. In addition to tablets for immediate use, we have material to produce 9 million more treatments," says the report of the Ministry. The federal government recently bought a batch of 800 thousand doses, of which 50 thousand to reach the country next week and the remainder in September.
Care
Despite the increased number of deaths (11 in the balance of yesterday) and cases of contamination, the recommendations of the Ministry of Health have not changed. Anyone who has symptoms such as sudden fever, cough, headache, joint and muscle pain and rhinorrhea, should seek a doctor or health service, as is common with influenza.
The primary care are: wash hands thoroughly and often with soap and water, avoid touching eyes, mouth and nose after contact with surfaces, do not share personal effects and cover the mouth and nose with disposable tissue when coughing or sneezing.
Source: http://noticias.uol.com.br/ultnot/agencia/2009/07/17/ult4469u43817.jhtm
Last edited: